Millendo is working to ease the burden of patients with severe endocrine diseases
Millendo is leveraging novel biological insights to advance a portfolio of endocrine therapeutics
Millendo is restoring hormonal balance to patients with endocrine diseases
March 29, 2019Millendo Reports Full Year 2018 Operating and Financial Results
March 19, 2019Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome
